Published online Apr 26, 2022. doi: 10.12998/wjcc.v10.i12.3773
Peer-review started: July 5, 2021
First decision: July 26, 2021
Revised: July 26, 2021
Accepted: April 3, 2022
Article in press: April 3, 2022
Published online: April 26, 2022
Processing time: 290 Days and 1.5 Hours
From an evidence-based perspective, this study examined the influence of melatonin on the prevention of delirium in hospitalized patients. The results suggest that in patients with delusional behavior and dermatology ward (ICU) patients, the effect of melatonin on delirium was confirmed. Thus, melatonin may be a treatment option for delirium with careful design for different types of respondents, and more standardized options.
Recently, research on the effect of melatonin on the occurrence of delirium in hospitalized patients has attracted more and more attention. However, it is unknown whether melatonin can play a role in different types of hospitalized patients. The use of melatonin to prevent delirium has aroused increasing interest in doctors. However, whether melatonin can play a role in different types of hospitalized patients needs further research.
We conducted a meta-analysis, mainly for one purpose. It was based on high-quality studies with a large enough sample size to calculate a reliable estimate of the incidence of melatonin in preventing delirium in hospitalized patients, and to evaluate the role of melatonin in reducing the incidence of delirium in different types of patients.
Various databases were searched and relevant studies on the incidence of delirium treated with melatonin in hospitalized patients were retrieved. In our meta-analysis, fixed-effects and random-effects models were used to estimate the incidence of delirium in hospitalized patients. Publication and sensitivity bias analysis was used to test the robustness of the data.
A total of 18 studies involving 2137 patients were eligible for this review. Melatonin was shown to be more effective in reducing the incidence of delirium in hospitalized medical patients, and the findings were statistically significant (P < 0.01).
Melatonin can reduce the incidence of delirium in medical patients, but its impact on reducing the incidence of delirium in patients with behavioral disorders and ICU patients is unclear.
Our meta-analysis showed that melatonin can reduce the incidence of delirium in hospitalized medical patients. Unfortunately, limited research has shown that the benefit is not seen in surgical patients or ICU patients. Further study to determine the role of melatonin in reducing the incidence of delirium in surgical and ICU patients is required.